Showing 451-460 of 1342 results for "".
AAD Wrap: What To Know from Dermatology’s Biggest Meeting
https://practicaldermatology.com/issues/april-2025/aad-wrap-what-to-know-from-dermatologys-biggest-meeting/35623/The 2025 American Academy of Dermatology (AAD) Annual Meeting brought together the dermatology community this past March to exchange groundbreaking research, innovative treatments, and technological advancements. For 4 days in Orlando, the meeting served as the hub of the dermatology profession, delTake a Load Off Your Back: A How-To Guide
https://practicaldermatology.com/topics/practice-management/take-a-load-off-your-back-a-how-to-guide/22076/Dermatologic surgeons spend their days bent over exam tables to perform procedures. Their backs may suffer.Cultural and Aesthetic Considerations in Patients with Skin of Color
https://practicaldermatology.com/programs/practical-dermatology/cultural-and-aesthetic-considerations-in-patients-with-skin-of-color/24211/Culture is influenced by the prevalent art, customs, religions, and social institutions of one’s environment. As the human population continues to evolve, the world population is becoming more multicultural and multiethnic. By the year 2050, approximately 50% of the US population will include peopleMaximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that businInvestigating the Potential for Neuromodulators in the Treatment of Psoriasis
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/investigating-the-potential-for-neuromodulators-in-the-treatment-of-psoriasis/21398/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Scurvy in the Modern Era
https://practicaldermatology.com/topics/general-topics/scurvy-in-the-modern-era/21456/One of the winning presentations given by dermatology residents at Cosmetic Surgery Forum.Cutaneous Metastasis of Adenocarcinoma with an Unknown Primary Tumor
https://practicaldermatology.com/youngmd-connect/resident-resource-center/cutaneous-metastasis-of-adenocarcinoma-with-an-unknown-primary-tumor/20352/Report and discussion: Cutaneous metastasis of adenocarcinoma with an unknown primary tumor.Pain-free Dermatology: Minimizing Discomfort in Procedures for Children and Adults
https://practicaldermatology.com/topics/general-topics/pain-free-dermatology-minimizing-discomfort-in-procedures-for-children-and-adults/21000/It may be useful to review some of the techniques and approaches used to minimize pain.Comorbidities in Immune-mediated Skin Disorders: What’s Coming
https://practicaldermatology.com/issues/january-february-2025/comorbidities-in-immune-mediated-skin-disorders-whats-coming/32968/Comorbidities in immune-mediated skin disorders (IMSDs) occur frequently and have a significant impact on disease severity, treatment, prognosis, and quality of life.